{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T15:38:25Z","timestamp":1782488305532,"version":"3.54.5"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:00:00Z","timestamp":1776988800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:00:00Z","timestamp":1776988800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Arch Otorhinolaryngol"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s00405-026-10184-1","type":"journal-article","created":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T22:16:27Z","timestamp":1776982587000},"page":"3795-3807","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Evaluating the efficacy and safety of Stapokibart (CM310) in the treatment of uncontrolled seasonal allergic rhinitis based on real-world research"],"prefix":"10.1007","volume":"283","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-4788-9576","authenticated-orcid":false,"given":"Jia","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaifu","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dingqiang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,24]]},"reference":[{"issue":"11","key":"10184_CR1","doi-asserted-by":"publisher","first-page":"3383","DOI":"10.1111\/all.15044","volume":"76","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Lan F, Zhang L (2021) Advances and highlights in allergic rhinitis. Allergy 76(11):3383\u20133389. https:\/\/doi.org\/10.1111\/all.15044","journal-title":"Allergy"},{"issue":"1","key":"10184_CR2","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/s41572-020-00227-0","volume":"6","author":"J Bousquet","year":"2020","unstructured":"Bousquet J et al (2020) Allergic rhinitis. Nat Rev Dis Primers 6(1):95. https:\/\/doi.org\/10.1038\/s41572-020-00227-0","journal-title":"Nat Rev Dis Primers"},{"issue":"9809","key":"10184_CR3","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1016\/s0140-6736(11)60130-x","volume":"378","author":"AN Greiner","year":"2011","unstructured":"Greiner AN et al (2011) Allergic rhinitis. Lancet 378(9809):2112\u20132122. https:\/\/doi.org\/10.1016\/s0140-6736(11)60130-x","journal-title":"Lancet"},{"issue":"3","key":"10184_CR4","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1111\/j.1398-9995.2005.00751.x","volume":"60","author":"V Bauchau","year":"2005","unstructured":"Bauchau V, Durham SR (2005) Epidemiological characterization of the intermittent and persistent types of allergic rhinitis. Allergy 60(3):350\u2013353. https:\/\/doi.org\/10.1111\/j.1398-9995.2005.00751.x","journal-title":"Allergy"},{"issue":"2","key":"10184_CR5","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.pop.2023.01.003","volume":"50","author":"EJ Czech","year":"2023","unstructured":"Czech EJ, Overholser A, Schultz P (2023) Allergic Rhinitis Prim Care 50(2):159\u2013178. https:\/\/doi.org\/10.1016\/j.pop.2023.01.003","journal-title":"Allergic Rhinitis Prim Care"},{"issue":"8","key":"10184_CR6","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1111\/cea.70118","volume":"55","author":"N Wang","year":"2025","unstructured":"Wang N et al (2025) Allergic Rhinitis in China: Trends, Challenges and Implications Over the Past Two Decades. Clin Exp Allergy 55(8):648\u2013658. https:\/\/doi.org\/10.1111\/cea.70118","journal-title":"Clin Exp Allergy"},{"issue":"9","key":"10184_CR7","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1159\/000530842","volume":"184","author":"Z Gu","year":"2023","unstructured":"Gu Z et al (2023) Analysis of Multimorbidity of Moderate to Severe Allergic Rhinitis in Children: A Real-World Study. Int Arch Allergy Immunol 184(9):882\u2013892. https:\/\/doi.org\/10.1159\/000530842","journal-title":"Int Arch Allergy Immunol"},{"key":"10184_CR8","doi-asserted-by":"publisher","unstructured":"Mims JW (2014) Epidemiology of allergic rhinitis. Int Forum Allergy Rhinol, 4 Suppl 2: pp. S18-20 https:\/\/doi.org\/10.1002\/alr.21385","DOI":"10.1002\/alr.21385"},{"issue":"4","key":"10184_CR9","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1111\/all.16029","volume":"79","author":"S Dramburg","year":"2024","unstructured":"Dramburg S et al (2024) Heterogeneity of sensitization profiles and clinical phenotypes among patients with seasonal allergic rhinitis in Southern European countries-The IT.2020 multicenter study. Allergy 79(4):908\u2013923. https:\/\/doi.org\/10.1111\/all.16029","journal-title":"Allergy"},{"issue":"2","key":"10184_CR10","doi-asserted-by":"publisher","first-page":"156","DOI":"10.4168\/aair.2019.11.2.156","volume":"11","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Zhang L (2019) Increasing Prevalence of Allergic Rhinitis in China. Allergy Asthma Immunol Res 11(2):156\u2013169. https:\/\/doi.org\/10.4168\/aair.2019.11.2.156","journal-title":"Allergy Asthma Immunol Res"},{"issue":"2","key":"10184_CR11","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1111\/all.14561","volume":"76","author":"M Zheng","year":"2021","unstructured":"Zheng M et al (2021) Clinical characteristics of allergic rhinitis patients in 13 metropolitan cities of China. Allergy 76(2):577\u2013581. https:\/\/doi.org\/10.1111\/all.14561","journal-title":"Allergy"},{"issue":"12","key":"10184_CR12","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1111\/cea.14236","volume":"52","author":"Z Jiang","year":"2022","unstructured":"Jiang Z et al (2022) Broussonetia papyrifera (paper mulberry) pollen is an important cause of allergic rhinitis in Southwest China. Clin Exp Allergy 52(12):1448\u20131451. https:\/\/doi.org\/10.1111\/cea.14236","journal-title":"Clin Exp Allergy"},{"issue":"2","key":"10184_CR13","doi-asserted-by":"publisher","first-page":"e12116","DOI":"10.1002\/clt2.12116","volume":"12","author":"W Wang","year":"2022","unstructured":"Wang W et al (2022) Environmental and sensitization variations among asthma and\/or rhinitis patients between 2008 and 2018 in China. Clin Transl Allergy 12(2):e12116. https:\/\/doi.org\/10.1002\/clt2.12116","journal-title":"Clin Transl Allergy"},{"issue":"4","key":"10184_CR14","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s11596-011-0469-1","volume":"31","author":"J Shen","year":"2011","unstructured":"Shen J et al (2011) Epidemiological features of allergic rhinitis in four major cities in Western China. J Huazhong Univ Sci Technolog Med Sci 31(4):433. https:\/\/doi.org\/10.1007\/s11596-011-0469-1","journal-title":"J Huazhong Univ Sci Technolog Med Sci"},{"issue":"3","key":"10184_CR15","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1046\/j.1365-2222.1998.00237.x","volume":"28","author":"P White","year":"1998","unstructured":"White P et al (1998) Symptom control in patients with hay fever in UK general practice: how well are we doing and is there a need for allergen immunotherapy? Clin Exp Allergy 28(3):266\u2013270. https:\/\/doi.org\/10.1046\/j.1365-2222.1998.00237.x","journal-title":"Clin Exp Allergy"},{"issue":"10","key":"10184_CR16","doi-asserted-by":"publisher","first-page":"e71409","DOI":"10.7759\/cureus.71409","volume":"16","author":"CO Siti Sarah","year":"2024","unstructured":"Siti Sarah CO, Mohd Ashari NS (2024) Exploration of Allergic Rhinitis: Epidemiology, Predisposing Factors, Clinical Manifestations, Laboratory Characteristics, and Emerging Pathogenic Mechanisms. Cureus 16(10):e71409. https:\/\/doi.org\/10.7759\/cureus.71409","journal-title":"Cureus"},{"issue":"4","key":"10184_CR17","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1002\/alr.23090","volume":"13","author":"SK Wise","year":"2023","unstructured":"Wise SK et al (2023) International consensus statement on allergy and rhinology: Allergic rhinitis\u2009\u2013\u20092023. Int Forum Allergy Rhinol 13(4):293\u2013859. https:\/\/doi.org\/10.1002\/alr.23090","journal-title":"Int Forum Allergy Rhinol"},{"issue":"4","key":"10184_CR18","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1097\/aci.0000000000000921","volume":"23","author":"M Zhang","year":"2023","unstructured":"Zhang M, Ao T, Cheng L (2023) Highlights of the treatment of allergic rhinitis according to Chinese guidelines. Curr Opin Allergy Clin Immunol 23(4):334\u2013340. https:\/\/doi.org\/10.1097\/aci.0000000000000921","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"6","key":"10184_CR19","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1016\/j.jaip.2024.03.023","volume":"12","author":"L Klimek","year":"2024","unstructured":"Klimek L et al (2024) Current Management of Allergic Rhinitis. J Allergy Clin Immunol Pract 12(6):1399\u20131412. https:\/\/doi.org\/10.1016\/j.jaip.2024.03.023","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"4","key":"10184_CR20","doi-asserted-by":"publisher","first-page":"104355","DOI":"10.1016\/j.amjoto.2024.104355","volume":"45","author":"F AlTheyab","year":"2024","unstructured":"AlTheyab F et al (2024) The efficacy and safety of intra-nasal corticosteroid spray in pediatric: Systematic review. Am J Otolaryngol 45(4):104355. https:\/\/doi.org\/10.1016\/j.amjoto.2024.104355","journal-title":"Am J Otolaryngol"},{"key":"10184_CR21","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.2147\/jaa.S321332","volume":"14","author":"PT Daley-Yates","year":"2021","unstructured":"Daley-Yates PT et al (2021) Intranasal Corticosteroids: Topical Potency, Systemic Activity and Therapeutic Index. J Asthma Allergy 14:1093\u20131104. https:\/\/doi.org\/10.2147\/jaa.S321332","journal-title":"J Asthma Allergy"},{"issue":"11","key":"10184_CR22","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s11882-020-00960-2","volume":"20","author":"J McDonnell","year":"2020","unstructured":"McDonnell J, Weller K, Pien LC (2020) Safety of Intranasal Steroids: an Updated Perspective. Curr Allergy Asthma Rep 20(11):69. https:\/\/doi.org\/10.1007\/s11882-020-00960-2","journal-title":"Curr Allergy Asthma Rep"},{"issue":"2","key":"10184_CR23","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s11882-022-01063-w","volume":"23","author":"IM Vlastos","year":"2023","unstructured":"Vlastos IM et al (2023) Multimorbidities in Allergic Rhinitis-Current Evidence from Epidemiological Studies, Treatment Trials, and Molecular Data. Curr Allergy Asthma Rep 23(2):133\u2013140. https:\/\/doi.org\/10.1007\/s11882-022-01063-w","journal-title":"Curr Allergy Asthma Rep"},{"issue":"7","key":"10184_CR24","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1080\/17512433.2023.2225770","volume":"16","author":"C Trincianti","year":"2023","unstructured":"Trincianti C, Tosca MA, Ciprandi G (2023) Updates in the diagnosis and practical management of allergic rhinitis. Expert Rev Clin Pharmacol 16(7):669\u2013676. https:\/\/doi.org\/10.1080\/17512433.2023.2225770","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"4","key":"10184_CR25","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1080\/14656566.2024.2336082","volume":"25","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Zhang L (2024) Current challenges with adherence to pharmacotherapy in allergic rhinitis. Expert Opin Pharmacother 25(4):335\u2013338. https:\/\/doi.org\/10.1080\/14656566.2024.2336082","journal-title":"Expert Opin Pharmacother"},{"issue":"1","key":"10184_CR26","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.anai.2023.03.022","volume":"131","author":"J Tversky","year":"2023","unstructured":"Tversky J et al (2023) Randomized double-blind pilot study of universal, species abundant, multiallergen subcutaneous immunotherapy for moderate-severe allergic rhinitis. Ann Allergy Asthma Immunol 131(1):89\u201395. https:\/\/doi.org\/10.1016\/j.anai.2023.03.022","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"1","key":"10184_CR27","doi-asserted-by":"publisher","first-page":"15","DOI":"10.5415\/apallergy.0000000000000174","volume":"15","author":"M Wang","year":"2025","unstructured":"Wang M et al (2025) Stapokibart (CM310) in patients with uncontrolled seasonal allergic rhinitis (PHECDA): Rationale and design of a multicentre, randomized, double-blind, placebo-controlled study. Asia Pac Allergy 15(1):15\u201320. https:\/\/doi.org\/10.5415\/apallergy.0000000000000174","journal-title":"Asia Pac Allergy"},{"key":"10184_CR28","doi-asserted-by":"publisher","first-page":"102467","DOI":"10.1016\/j.eclinm.2024.102467","volume":"69","author":"Y Zhang","year":"2024","unstructured":"Zhang Y et al (2024) Efficacy and safety of stapokibart (CM310) in uncontrolled seasonal allergic rhinitis (MERAK): an investigator-initiated, placebo-controlled, randomised, double-blind, phase 2 trial. EClinicalMedicine 69:102467. https:\/\/doi.org\/10.1016\/j.eclinm.2024.102467","journal-title":"EClinicalMedicine"},{"issue":"7","key":"10184_CR29","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1038\/s41591-025-03651-5","volume":"31","author":"Y Zhang","year":"2025","unstructured":"Zhang Y et al (2025) Stapokibart for moderate-to-severe seasonal allergic rhinitis: a randomized phase 3 trial. Nat Med 31(7):2213\u20132221. https:\/\/doi.org\/10.1038\/s41591-025-03651-5","journal-title":"Nat Med"},{"issue":"2","key":"10184_CR30","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.amepre.2007.04.007","volume":"33","author":"RW Sanson-Fisher","year":"2007","unstructured":"Sanson-Fisher RW et al (2007) Limitations of the randomized controlled trial in evaluating population-based health interventions. Am J Prev Med 33(2):155\u2013161. https:\/\/doi.org\/10.1016\/j.amepre.2007.04.007","journal-title":"Am J Prev Med"},{"key":"10184_CR31","doi-asserted-by":"publisher","unstructured":"Subspecialty Group of Rhinology (2022) E.B.o.C.J.o.O.H.a.N.S., [Chinese guideline for diagnosis and treatment of allergic rhinitis (2022, revision)]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 57(2):106\u2013129. https:\/\/doi.org\/10.3760\/cma.j.cn115330-20211228-00828","DOI":"10.3760\/cma.j.cn115330-20211228-00828"},{"key":"10184_CR32","doi-asserted-by":"publisher","unstructured":"Cheng L (2022) Revising allergic rhinitis guidelines to standardize clinical diagnosis and treatment]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 57(4):413\u2013417. https:\/\/doi.org\/10.3760\/cma.j.cn115330-20220325-00134","DOI":"10.3760\/cma.j.cn115330-20220325-00134"},{"issue":"10","key":"10184_CR33","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1001\/jama.2024.0530","volume":"331","author":"JA Bernstein","year":"2024","unstructured":"Bernstein JA et al (2024) Allergic Rhinitis: A Review. JAMA 331(10):866\u2013877. https:\/\/doi.org\/10.1001\/jama.2024.0530","journal-title":"JAMA"},{"key":"10184_CR34","doi-asserted-by":"publisher","first-page":"1184552","DOI":"10.3389\/fphar.2023.1184552","volume":"14","author":"KK Soe","year":"2023","unstructured":"Soe KK et al (2023) Comparative efficacy and acceptability of licensed dose intranasal corticosteroids for moderate-to-severe allergic rhinitis: a systematic review and network meta-analysis. Front Pharmacol 14:1184552. https:\/\/doi.org\/10.3389\/fphar.2023.1184552","journal-title":"Front Pharmacol"},{"key":"10184_CR35","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.2147\/jaa.S273478","volume":"16","author":"G Ciprandi","year":"2023","unstructured":"Ciprandi G (2023) Self-Management in Allergic Rhinitis: Strategies, Outcomes and Integration into Clinical Care. J Asthma Allergy 16:1087\u20131095. https:\/\/doi.org\/10.2147\/jaa.S273478","journal-title":"J Asthma Allergy"},{"issue":"10","key":"10184_CR36","doi-asserted-by":"publisher","first-page":"e71408","DOI":"10.7759\/cureus.71408","volume":"16","author":"I Yamani","year":"2024","unstructured":"Yamani I et al (2024) Efficacy of Biologic Therapies in the Management of Allergic Rhinitis: A Systematic Review. Cureus 16(10):e71408. https:\/\/doi.org\/10.7759\/cureus.71408","journal-title":"Cureus"}],"container-title":["European Archives of Oto-Rhino-Laryngology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-026-10184-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00405-026-10184-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-026-10184-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T01:03:45Z","timestamp":1781053425000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00405-026-10184-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,24]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["10184"],"URL":"https:\/\/doi.org\/10.1007\/s00405-026-10184-1","relation":{},"ISSN":["0937-4477","1434-4726"],"issn-type":[{"value":"0937-4477","type":"print"},{"value":"1434-4726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,24]]},"assertion":[{"value":"7 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study received ethical approval from the independent medical ethics committee at Sichuan University affiliated Chengdu Second People\u2019s Hospital (Approval number: No. [KY] PJ2025415), and all participants provided written informed consent before enrollment.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration of competing interest"}}]}}